MilliporeSigma has partnered with Acticor Biotech SAS to provide its Provantage end-to-end services for accelerated development and manufacturing of Acticor’s antibody fragment used for the primary treatment of ischemic stroke.  MilliporeSigma’s Provantage solution is a comprehensive suite of products and services enabling biopharmaceutical companies to accelerate progress of molecules into the clinic and toward commercialization. “Our Provantage end-to-end solution will ...